SR ONE CAPITAL MANAGEMENT, LP Q3 2022 Filing

Filed November 8, 2022

Portfolio Value

$218.7B

Holdings

4

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
5,500,007$103.2B47.19%
2
DSGNDESIGN THERAPEUTICS INC
5,626,476$94.1B43.01%
3
NKTXNKARTA INC.
1,333,333$17.5B8.02%
4
EFTREFFECTOR THERAPEUTICS INC
6,822,114$3.9B1.78%